Loading...

This program is preliminary and subject to change.

 

FRIDAY MAY 31

1300-1730

CACB Oral Exams

 

 

SATURDAY JUNE 1

0800-1130

CACB Oral Exams

0900-1700

CSCC 2018-2019 Council Meeting

1400-1700

CACB 2018-2019 Board of Directors Meeting

 

 

SUNDAY JUNE 2

0800-1130

CACB Oral Exams

0800-0930

Scientific Workshops – Morning Part 1

0930-1100

Scientific Workshops – Morning Part 2

1100-1300

CSCC Charity Run

1300-1430

Scientific Workshops – Afternoon Part 1

1430-1600

Scientific Workshops – Afternoon Part 2

1600-1730

Special Interest Group and Committee Meetings

  • EPOCC
  • CACB Accreditation Committee
  • Pediatric Focus Group

1730-1830

New Member Reception

1830-1930

Opening Keynote: Addiction, HIV, and Hepatitis C – Delivering Efficient and Effective Care

1930-2200

Opening Reception at The New Brunswick Museum Hall of Great Whales

 

 

MONDAY JUNE 3

0730-0830

Clinical Biochemistry Editorial Board

 

Breakfast Roundtables

0845-1200

Symposium 1: Forensics in Laboratory Medicine

1200-1900

Lunch, Exhibit and Poster Viewing

1400-1500

Industry Workshops

1600-1700

Industry Workshops

1700-1900

Wine & Cheese Reception with Exhibitors

 

 

TUESDAY JUNE 4

0730-0830

Industry Workshops

0900-1200

Symposium 2: When One Size Fits All Doesn’t Fit

1200-1330

Lunch and Exhibit Viewing

1300-1330

CSCC Council/Vendor Meeting

1330-1630

Symposium 3: Artificial Intelligence

1630-1730

CSCC Annual General Meeting

CSCC “Town Hall”

1730-1815

CACB Annual General Meeting

1830-2230

President’s Reception and Awards Banquet at Cornerstone Performance & Event Venue

 

 

WEDNESDAY JUNE 5

0730-0830

Breakfast Roundtables

0900-1200

Symposium 4: Harmonization of Quality

1200-1600

Committee Meetings & Special Interest Group Meetings

  • 1215-1300 CSCC Annual Meetings Committee
  • 1300-1400 Special Interest Group Meetings:
    • Toxicology SIG
    • MG SIG
    • hRI WG
  • 1400-1500 Special Interest Group Meetings:
    • Lab Utilization SIG
    • MG WG (1400-1600)
  • 1500-1600 CSCC 2020 Committee

1600-1700

CSCC 2019-2020 Council Meeting

CACB 2019-2020 Board of Directors Meeting

Back to top

 

 

Opening Keynote: Addiction, HIV, and Hepatitis C – Delivering Efficient and Effective Care
Sunday June 2, 1830-1930

 

Duncan Webster, Division of Infectious Disease, Department of Medicine, Horizon Health Network, Saint John

Back to top

 

 

Symposium 1: Forensics in Laboratory Medicine
Monday June 3, 0900-1200

 

Learning Objectives:

At the end of this session participants will be able to:

  • Gain an appreciation for the role of the laboratory in forensic testing.
  • Understand the differences in quality assurance between clinical and forensic laboratories.
  • Gain insight into the nuances of expert witness testimony.

 

0900-0950

A Survival Guide to Forensics for the Clinical Chemist

Frederick Strathmann, Vice President of Quality Assurance, Director of New Technology & Innovation, Assistant Laboratory Director, NMS Labs, Willow Grove, Pennsylvania

 

Learning Objectives:

At the end of this session participants will be able to:

  • List the major regulatory bodies and guidance documents applicable to forensic testing.
  • Summarize the important differences and similarities with effective testimony in clinical and forensic contexts.
  • Assess the needed approach to effective innovation in the area of forensic science.

This presentation will provide an introduction to forensics from the perspective of a trained clinical chemist. Topics will include a brief introduction to the world of forensics for those with little to no training in forensics, an overview of key similarities and differences in quality assurance between forensic and clinical labs, and the challenges with innovation. This session will be of value to all clinical laboratory staff that may find themselves unexpectedly involved on the forensic side of laboratory testing.

 

0950-1020

Refreshment Break

 

1020-1110

Mock Trial

Matthew Bowes, Chief Medical Examiner, Nova Scotia

The Honorable Lucie Mathurin, Provincial Court Judge, New Brunswick

Patrick Wilbur, Crown prosecutor, New Brunswick

 

1100-1200

Roundtable Panel Discussion

Panelists:

Matthew Bowes, Chief Medical Examiner, Nova Scotia

The Honorable Lucie Mathurin, Provincial Court Judge, New Brunswick

Curtis Oleschuk, St. Boniface Hospital, Winnipeg

Frederick Strathmann, Vice President of Quality Assurance, Director of New Technology & Innovation, Assistant Laboratory Director, NMS Labs, Willow Grove, Pennsylvania

Patrick Wilbur, Crown Prosecutor, New Brunswick

Back to top

 

 

Symposium 2: When One Size Fits All Doesn’t Fit
Tuesday June 4, 0900-1200

 

Learning Objectives:

At the end of this session participants will be able to:

  • Identify the limitations of applying standard adult reference intervals to non-reference population groups.
  • Describe the considerations necessary to appropriately defining health in an aging/elderly individual.
  • Recognize the challenges of addressing infertility and the role of the laboratory in fertility treatment.

 

0900-0950

Rethinking Reference Intervals for Older Adults: Data from the Canadian Longitudinal Study on Aging (CLSA)

Cynthia Balion, St. Joseph’s Healthcare Hamilton

 

0950-1020

Refreshment Break

 

1020-1110

Laboratory Assessment of Gametes for Fertility Treatment

Sharon Mortimer, Oozoa Biomedical; Grace Fertility Centre, Vancouver

 

Learning Objectives:

At the end of this session participants will be able to:

  • Describe the functional basis for gamete assessment methods in the ART (assisted reproductive technologies) laboratory.
  • Describe the predictive value of oocyte morphology on embryo developmental potential.
  • Describe the limitations of a basic (WHO-type) semen analysis in predicting fertility.

 

1110-1200

Lightening Talks

 

Learning Objectives:

At the end of this session participants will be able to:

  • Discuss key special considerations for laboratory testing in neonate / pediatric, transgender, and ethnic / minority populations.
  • Outline an algorithm for providing constructive feedback on the content and organization of an oral presentation.
  • Apply the observed communication strategies to enhance audience engagement during oral presentations.

Presentations include:

  • Neonates or Pediatrics
    Lawrence de Koning, University of Calgary; Alberta Public Laboratories
    Heather Paul,
  • Transgender Individuals
    Loralie Langman, Mayo Laboratories, Minneapolis
    Zahraa Mohamed-Ali,
  • Ethnicity / Minority Populations
    Stephen Hill, McMaster University
    Ola Ismail,

Back to top

 

 

Symposium 3: Artificial Intelligence
Tuesday June 4, 1330-1630

 

Learning Objectives:

At the end of this session participants will be able to:

  • Identify the basic principles of Artificial Intelligence and current applications, limits and potential pitfalls.
  • Recognize the current and future use of Artificial Intelligence in laboratory medicine and its potential for disruptive innovations.
  • Identify the ethical, data privacy and intellectual property aspects of the use of Artificial Intelligence in healthcare.

 

1330-1430

Introduction to Artificial Intelligence

Johan Saba, Seed AI, Montreal

 

Learning Objectives:

At the end of this session participants will be able to:

  • Identify the role of domain/sector translation in the context of data science and artificial intelligence.
  • Develop a strong understanding of data science and machine learning with concrete examples.
  • List the limitations of linear models and how deep learning solves them.

 

1430-1510

Using Analytics and Machine Learning to Enhance Clinical Laboratory Diagnosis

Jason Baron, Harvard Medical School; Massachusetts General Hospital, Boston

 

Learning Objectives:

At the end of this session participants will be able to:

  • Describe key fundamentals of machine learning.
  • Identify opportunities to apply analytics and machine learning to improve clinical laboratory diagnosis.
  • Evaluate emerging strategies for clinical decision support.

 

1510-1540

Refreshment Break

 

1540-1630

Ethical, Intellectual Property and Data Privacy Considerations Related to AI in Healthcare

Mélanie Bourassa Forcier, Université de Sherbrooke

 

Learning Objectives:

At the end of this session participants will be able to:

  • Identify the ethical issues of privacy in relation to implementation of AI in Healthcare.
  • Identify liability issues in relation to implementation of AI in Healthcare.
  • Determine patentability issues in relation to implementation of AI in Healthcare.

Back to top

 

 

Symposium 4: Harmonization of Quality
Wednesday June 5, 0900-1200

 

Learning Objectives:

At the end of this session participants will be able to:

  • Describe the current status in the harmonization of quality indicators.
  • Discuss the progress towards consensus for the determination of reference intervals.
  • Identify opportunities for laboratories to improve patient care through the Choosing Wisely campaign.

 

0900-0945

Quality Indicators in Laboratory Medicine: The Path to Patient Safety

Vincent De Guire, Hôpital Maisonneuve-Rosemount; Grappe OPTILAB Montréal-CHUM, Montréal

 

0945-1030

Reference Interval Harmonization in Canada: An Update from the CSCC Working Group

Jennifer Taher, University of Toronto

 

1030-1045

Refreshment Break

 

1045-1110

Indirect Methods for Estimating Reference Intervals – Ready for Clinical Use?

Thomas Streichert, Institut für Klinische Chemie, University of Cologne

 

1100-1200

Addressing Laboratory Test Over-utilization Through Collaboration

Lisa K. Hicks, University of Toront; Li Ka Shing Knowledge Institute; St. Michaels Hospital

Back to top